US Stock Reports, Quotes and News
Ajay Srivastava, CEO of Dimensions Corporate, advises investing in ABB, Siemens, IndiGo, Indian Hotels, and Hero Moto if the market falls 30-40%. These companies, known for their performance and economic ties, are recommended. Furthermore, smaller IT firms linked to the BFSI sector show promise. The defense sector, shipyards, QSR companies, multiplex companies, and consumer companies are currently underperforming.
Gartner\’s DD Mishra anticipates AI-led growth in 2024-25, with CIOs relying on consulting services amid uncertainties. Crisis drives IT spending, while niche areas like midcap IT, ER&D, and automotive industry are expected to outperform. Mishra says: \”We will see disruptions in the short term, but the long term outlook is positive.\”
Nilesh Shah predicts ABB, Siemens, L&T\’s continued dominance in EMI. Key players like Hitachi Energy, KSB, and TD Power drive sector growth. India aims for a $10 trillion economy, focusing on diverse sectors.
Harshit Kapadia discusses the positive export momentum in the defence sector, citing increased export demand, growth in manufacturing bigger equipment, and Indian companies\’ strong positioning in global markets. Anticipates continued order inflow momentum and potential valuation expansion.
As the Q4 FY24 earnings season is going on, Goldman Sachs (NYSE:GS) analysts have recalibrated their projections for the Indian pharmaceutical sector, factoring in a spectrum of variables from monthly sales data to currency fluctuations. Notably, the sector continues to trade at valuations exceeding one standard deviation above its five-year average, largely propelled by the resilience of major players like Sun Pharma (NS:SUN), Cipla (NS:CIPL), and Divi’s Laboratories.
The finance cost of the non-banking financial company rose in tandem with the revenue to ₹847 crore. Loan disbursement in the quarter was ₹12,869.35 crore up around 14% from the corresponding period last year.
Markets anticipate election impact. May series will be volatile, says Rahul Ghose of Hedged.in. He says a stock-specific approach is advisable now and that he prefers Hindustan Unilever, Elecon and Just Dial and recommends exiting Exide. Nifty\’s crucial levels are at 21,700-21,800, 22,000. PSU banks are favored while Nifty Pharma index is pivotal at 18,700. IPCA labs strong.
Sandip Sabharwal advises caution in volatile markets due to Middle East tensions and evolving global trends. Market dips should be carefully assessed for investment opportunities. \”The first level where I would like to start buying more aggressively will be more near 21,000 of the Nifty and if by chance it falls further to between 20,000 and 20,500, then I would like to be fully deployed at that stage.\”
Q4 Results Today: Mixed Q4 earnings for IT sector with TCS outperforming and Infosys lagging. Awaited reports from companies like Wipro, Hindustan Zinc, Sejal Glass, and others will provide further insight into the sector\’s performance.
Hemang Jani remains cautious on the IT sector. He says \”the only positive takeaway is that the market is already sensing that there would be a significant negative growth of about 1% to 1.8% in terms of quarterly revenue growth for Infosys. The next year guidance was anywhere from 3% to 5%, which is mediocre. So, it would be best to stay away from IT till we get more colour on growth.\”
Anand Tandon advises focusing on tactical plays in private sector banks amidst market sector value concerns. He highlights the power sector\’s growth potential but suggests waiting for better entry points for investment in various sectors.